Login / Signup

Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.

Ying-Ying MaZe-Liang WeiYa-Jing XuJi-Min ShiHai YiYong-Rong LaiEr-Lie JiangSan-Bin WangTao WuLei GaoLi GaoPei-Yan KongQin WenHai BaiYu LiYi-Geng CaoQiao-Chuan LiZhong-Ming ZhangBei-Cai LiuYi SuXiao-Yu LaiXia MaTing-Ting ChengYi LuoXi ZhangCheng Zhang
Published in: Cancer (2023)
Poor minimal residual disease clearance pretransplanation is an independent prognostic risk factor for long-term survival after allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome with excess blasts.
Keyphrases
  • allogeneic hematopoietic stem cell transplantation
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • clinical trial
  • double blind